ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Materials Science & Technology
The objectives of MSTD are: promote the advancement of materials science in Nuclear Science Technology; support the multidisciplines which constitute it; encourage research by providing a forum for the presentation, exchange, and documentation of relevant information; promote the interaction and communication among its members; and recognize and reward its members for significant contributions to the field of materials science in nuclear technology.
Meeting Spotlight
Utility Working Conference and Vendor Technology Expo (UWC 2024)
August 4–7, 2024
Marco Island, FL|JW Marriott Marco Island
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2024
Jan 2024
Latest Journal Issues
Nuclear Science and Engineering
August 2024
Nuclear Technology
Fusion Science and Technology
Latest News
Vogtle-3 shuts down for valve issue
One of the new Vogtle units in Georgia was shut down unexpectedly on Monday last week for a valve issue that has since been investigated and repaired. According to multiple local news outlets, Georgia Power reported on July 17 that Unit 3 was back in service.
Southern Company spokesperson Jacob Hawkins confirmed that Vogtle-3 went off line at 9:25 p.m. local time on July 8 “due to lowering water levels in the steam generators caused by a valve issue on one of the three main feedwater pumps.”
H. Thiele, F.-M. Börst
Nuclear Technology | Volume 168 | Number 3 | December 2009 | Pages 867-870
Shielding | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (PART 3) / Radiation Protection | doi.org/10.13182/NT09-A9320
Articles are hosted by Taylor and Francis Online.
The purpose of this research was to make shielding benchmark calculations with the new Standardized Computer Analyses for Licensing Evaluation (SCALE) shielding sequence Monaco with Automated Variance Reduction Importance Calculations (MAVRIC) and compare with SCALE SAS4/MORSE calculations as well as dose rate measurements for the German storage/transport cask CASTOR® high active waste (HAW) 20/28 CG. MAVRIC with improved transport methodology is the successor of SAS4 and was released as part of SCALE version 6 in 2009. The new calculations with MAVRIC resolve discrepancies of results obtained with SAS4 in comparison to measured data. Cask areas with heterogeneous structures like trunnions and ducts are of special interest.Based on dose rate measurements for neutron and gamma radiation on a CASTOR® HAW 20/28 CG cask and to extend our own shielding calculations done with the SCALE SAS4/MORSE sequence, the new SCALE shielding sequence MAVRIC/Monaco has been used for comprehensive calculations to treat problematic cask shielding regions like trunnion areas and ducts in the cask lid.The calculations with the SAS4 sequence are carried out with SCALE v4.4a. The prerelease test version of the MAVRIC sequence was added to SCALE v5.1 for testing purposes. The dose rate measurements are carried out for a single CASTOR® HAW 20/28 CG cask in storage configuration. Loading plans are used for calculating the source strength and the spectra of the inventory.Calculations with the new MAVRIC sequence and the typical SCALE group shielding library consisting of 27 neutron and 18 gamma groups for points on the surface at the cask at midheight and in front of the trunnions show results that are closer to the measured dose rates than the SAS4 calculations.First dose rate calculations with the new SCALE shielding sequence MAVRIC are presented. They show a better agreement to the measured data than the SAS4 sequence, especially for more complex regions. The reason is the three-dimensional treatment of the variance-reduction parameters in the new MAVRIC sequence as opposed to the one-dimensional biasing treatment in SAS4.